CO.DON negotiates with Xintela on the establishment of a joint venture

 

On 5 July 2018, CO.DON AG has signed a letter of intent (LOI) with Xintela AB, Lund (Sweden), by which the two companies have agreed to start negotiations regarding the establishment of a joint venture for the development and commercialization of...

More

Breakthrough in genetic engineering: Emmanuelle Charpentier wins Kavli Prize

Emmanuelle Charpentier, director at the Max Planck Institute for Infection Biology in Berlin, is among the winners of the internationally renowned Kavli prize. She is honoured for her pioneering work in developing the CRISPR-Cas9 system, a...

More

ProBioGen and Pionyr Immunotherapeutics Initiate a Second Immuno-Oncology Contract Development and Manufacturing Project

ProBioGen AG, a premier service and technology provider for complex therapeutic glycoproteins, and Pionyr Immunotherapeutics, an immuno-oncology company which develops next generation antibody-based therapeutics that target the tumor...

More

RaySearch and Eckert & Ziegler BEBIG enter into partnership regarding brachytherapy

RaySearch, a medical technology company for innovative software solutions, and Eckert & Ziegler BEBIG have signed a partnership agreement. Both the RayStation® treatment planning system and the RayCare oncology information system will be integrated...

More

NOXXON ISSUES TRANCHE OF ODIRNANE BONDS

NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announced today that it has issued another tranche of the ODIRNANE bonds (undated bonds...

More

Blood test enables reading out the internal clock

With a new blood test, researchers at the Charité – Universitätsmedizin Berlin can determine the state of the internal clock of a person. Once the internal rhythm of patient is known, drugs could be administered at particular times of day making them...

More

Restore Health – Therapies that cure

The European Commission (EC) announced that the FET Flagship RESTORE, which was initiated by the Berlin-Brandenburg Center for Regenerative Therapies (BCRT), has been selected to enter the next phase of the FET Flagship competition. A successful FET...

More

Berlin Health Innovations invests in 18 pioneering innovations

The validation fund of Berlin Health Innovations in cooperation with SPARK Berlin is entering its first round. 18 selected teams from the Charité – Universitätsmedizin Berlin and the Max Delbrück Center for Molecular Medicine in the Helmholtz...

More

ProBioGen and Nouscom Sign License Agreement for ProBioGen’s Technology Platform

Proprietary Duck Cell Line Serves as Large-Scale Production-Suitable Cell Substrate

More
Show more items